Insmed, Inc. (INSM)
194.21
-2.34
(-1.19%)
USD |
NASDAQ |
Dec 09, 16:00
193.70
-0.51
(-0.26%)
After-Hours: 18:20
Insmed EPS Diluted (Quarterly): -1.747 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| United Therapeutics Corp. | 7.161 |
| Alnylam Pharmaceuticals, Inc. | 1.840 |
| Madrigal Pharmaceuticals, Inc. | -5.079 |
| Vertex Pharmaceuticals, Inc. | 4.204 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -370.02M |
| Revenue (Quarterly) | 142.34M |
| Total Expenses (Quarterly) | 512.36M |
| Enterprise Value | 40.98B |
| Gross Profit Margin (Quarterly) | 78.29% |
| Profit Margin (Quarterly) | -260.0% |
| Earnings Yield | -3.18% |
| Normalized Earnings Yield | -2.887 |